Sovereign's medical changes welcomed

Sovereign has announced some changes to its Private Health medical product.  Included are:

• A change in the Surgical Hospitalisation benefit from $300,000 per person per annum to unlimited.  Whilst this looks to be a big change, in practice, it is unlikely to apply to many policyholders.  For those poor souls who do get to $300,000 in a year, the change will be welcome.  It would be interesting to learn from Sovereign, (and the other insurers), how many policyholders ever exceed the old $300,000 limit in a year.
• Up to $5,000 to cover breast symmetry surgery following a mastectomy.
• Outpatient physio and medications covered under the unlimited surgical benefit for 6 months after surgery (3 months for Majorcare 2003).
• Dental Support before certain chemotherapy and radiotherapy treatments.
• Some treatments covered worldwide.
• Increased Minor surgery cover.
• Increased Home Nursing benefit after surgery.
• These changes are all good for policyholders, but are hardly major.

The major change however, and one for which Sovereign is to be applauded, is the extending of cover for chemotherapy treatments approved by Medsafe but not funded by Pharmac, to its legacy products Absolute Health and Majorcare 2003.  (Note, that Majorcare issued prior to November 2003 didn’t exclude non-Pharmac treatments.)

It is impressive too, that the level of cover for these treatments is realistic rather than the token level ($10,000) introduced by Southern Cross recently.

Sovereign is also to be recognised for the fact that whilst their policy wording allows them to retrospectively change the terms of their medical products, they have never done so to restrict or remove a cover in place.  This change is a positive change for existing policyholders.